What does HER2 status mean for Lymphoma treatment
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
HER2 Status and Lymphoma Treatment
Great question! Let me clarify an important distinction: HER2 status is not typically relevant for most lymphomas, which is why you won't see it discussed in standard lymphoma guidelines. Let me explain why and when it might come up.
Why HER2 Isn't Standard for Lymphoma
HER2 (human epidermal growth factor receptor 2) is a protein that's primarily important in breast cancer and some gastric cancers. According to NCCN Guidelines for lymphomas—including Marginal Zone Lymphomas, Follicular Lymphoma, and Diffuse Large B-Cell Lymphomas—the focus is on different biomarkers that are specific to how lymphoma cells behave.
For lymphomas, doctors typically look for:
- CD20 status (a protein on B-cell lymphomas that's targeted by immunotherapy)
- CD10, BCL2, BCL6 (markers that help classify the lymphoma subtype)
- Mutations in specific genes like TP53, MYC, or BCL2 rearrangements
- ALK status (in certain large B-cell lymphomas)
The One Exception: Primary Mediastinal Lymphoma
There's a rare situation where HER2 might be relevant: in primary mediastinal large B-cell lymphoma (a lymphoma that develops in the chest). Some research has explored HER2 expression in this subtype, but it's not a standard treatment decision point in current NCCN Guidelines.
What You Should Do
If your pathology report mentions HER2:
- Ask your oncologist specifically: "Is HER2 status relevant to my lymphoma subtype and treatment plan?"
- Request clarification on which biomarkers are important for your specific diagnosis
- Ask: "What mutations or markers will guide my treatment decisions?"
Questions to ask your care team:
- What is my specific lymphoma subtype/diagnosis?
- Which biomarkers were tested on my biopsy?
- How do these biomarkers affect my treatment options?
- Are there any targeted therapies available based on my specific markers?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Lymphoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: